Vaccine clinical trial phases

Phase 1 (n=20-100) safety + immunogenicity dose-finding; Phase 2 (n=100-1000) expanded safety + efficacy signal; Phase 3 (n=1000-50000) efficacy + safety in target population; Phase 4 post-marketing surveillance. COVID-19 compressed…